Literature DB >> 12747948

Induction of human NK cell-mediated cytotoxicity by CD40 triggering on antigen presenting cells.

Rossella Sartorius1, Luciana D'Apice, Pasquale Barba, John Guardiola, Angela Santoni, Francesca Velotti, Piergiuseppe De Berardinis.   

Abstract

Engagement of CD40 on antigen presenting cells (APC) is central to the initiation of cell-mediated immune response. Here, we investigated the ability of CD40 ligation on APC to induce NK cell-mediated cytotoxicity in the human system and the mechanism(s) underlying this process. We showed that APC (consisting in adherent peripheral blood mononuclear cells) (PBMC), pre-stimulated with anti-CD40 monoclonal antibodies and co-cultured with autologous non-adherent PBMC for 5-9 days, induced CD3-/CD56+ NK cell-mediated cytotoxicity as well as CD3+/CD56+ T cell-mediated unrestricted cytotoxic activity. The generation of NK cell-mediated cytotoxicity was independent on cell-to-cell contact between CD40-triggered APC and NK cells. Moreover, we found that IL-12 did not play a role in NK cells induction by anti-CD40 priming, while IL-2 and IL-15 did play a role. Our results provide an insight into the mechanism by which NK cells are activated in peripheral blood and useful informations for therapeutic application of anti-CD40 antibodies.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12747948     DOI: 10.1016/s0008-8749(03)00060-1

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  3 in total

1.  Interleukin-12 is involved in the enhancement of human natural killer cell activity by Lactobacillus casei Shirota.

Authors:  K Takeda; T Suzuki; S-I Shimada; K Shida; M Nanno; K Okumura
Journal:  Clin Exp Immunol       Date:  2006-10       Impact factor: 4.330

2.  APX005M, a CD40 agonist antibody with unique epitope specificity and Fc receptor binding profile for optimal therapeutic application.

Authors:  Erin L Filbert; Pia K Björck; Minu K Srivastava; Frances R Bahjat; Xiaodong Yang
Journal:  Cancer Immunol Immunother       Date:  2021-01-03       Impact factor: 6.968

3.  Immune evasion in HPV- head and neck precancer-cancer transition is driven by an aneuploid switch involving chromosome 9p loss.

Authors:  William N William; Xin Zhao; Joy J Bianchi; Heather Y Lin; Pan Cheng; J Jack Lee; Hannah Carter; Ludmil B Alexandrov; Jim P Abraham; David B Spetzler; Steven M Dubinett; Don W Cleveland; Webster Cavenee; Teresa Davoli; Scott M Lippman
Journal:  Proc Natl Acad Sci U S A       Date:  2021-05-11       Impact factor: 12.779

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.